Live Breaking News & Updates on Neurexis Therapeutics Inc

Stay updated with breaking news from Neurexis therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Direct-to-Phase II SBIR Grant from NIH Awarded to Neurexis Therapeutics to Evaluate Neuroprotective Therapeutic in Stroke Preclinical Assessment Network (SPAN)

AURORA, CO (PRWEB) April 19, 2023 Neurexis Therapeutics, Incorporated, announces it has been awarded $900,000 in funding from a Direct-to-Phase II Small ....

Olivia Asfaha , Ulli Bayer , Neurexis Therapeutics Incorporated , Ii Small Business Innovation Research , University Of Colorado Anschutz Medical Campus , Stroke Preclinical Assessment Network , National Institutes Of Health , Neurexis Therapeutics Inc , National Institute Of Neurological Disorders , Co Principal Investigator , Business Innovation Research , National Institute , Neurological Disorders , National Institutes , Colorado Anschutz Medical Campus , Neurexis Therapeutics , Press Release ,

Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to Accelerate IND-Enabling Studies of Neuroprotective Therapeutic

Aurora, CO (PRWEB) October 14, 2021 Neurexis Therapeutics, Incorporated, announces it has been awarded a $496,145 grant from the National Institute of ....

Michael Artinger , Ulli Bayer , Neurexis Therapeutics Inc , Investor Network , University Of Colorado Anschutz Medical Campus , Neurexis Therapeutics Incorporated , Technology Venture Development , National Institute Of Neurological Disorders , National Institute , Neurological Disorders , Global Cerebral Ischemia , Venture Development , Colorado Anschutz Medical Campus , Neurexis Therapeutics , Press Release ,